News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Dégi László Csaba: Delivered the opening remarks at NZW 2025
Dégi László Csaba/LinkedIn
Feb 9, 2025, 14:31

Dégi László Csaba: Delivered the opening remarks at NZW 2025

Dégi László Csaba, President of the European Cancer Organisation, shared a post on LinkedIn:

“Just delivered the opening remarks at NZW 2025 in Hamburg!

Honored to represent ECO and discuss the future of oncology pharmacy with amazing colleagues from around the world. The energy in this room is incredible!”

Proceed to the video attached to the post.

cancer Dégi László Csaba NZW 2025 OncoDaily Oncology
Special Coverage
Blog
Feb 9, 2025, 14:31
Dégi László Csaba: Delivered the opening remarks at NZW 2025
Blog
Feb 9, 2025, 14:30
Françoise Meunier on the discussions on the future of cancer care at the World Economic Forum
Blog
Feb 9, 2025, 14:23
Aruni Ghose: Systematic review on exosomal biomolecules as noninvasive biomarkers in Prostate Cancer
Blog
Feb 9, 2025, 14:15
2025 Updates in Bladder and UT Cancers for Patients and their Loved Ones - Fred Hutchinson Cancer Center
Blog
Feb 9, 2025, 14:06
Be the Change: Transform Healthcare Together - ELPA
Blog
Feb 9, 2025, 13:58
Carmen Uscatu: The change you want to see
Science
Feb 9, 2025, 13:28
Myeloma Paper of the Day, February 9th, suggested by Robert Orlowski
Blog
Feb 9, 2025, 13:23
Sana Al Sukhun: Enjoyed joining Emirates Oncology Society
Blog
Feb 9, 2025, 12:29
NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%
Blog
Feb 9, 2025, 12:28
Jason Westin: The NIH will slash indirect costs on grants
Blog
Feb 9, 2025, 06:44
Sumanta K. Pal: We have extended our abstract submission deadline for SoCalGU25
Drugs
Feb 9, 2025, 05:06
Estela Rodriguez: A new option for a small subgroup of lung adenocarcinoma approved by FDA